TXMD

Therapeuticsmd
$2.07
+$0.01 (+0.49%)Jul 27, 2026
7.3GoodMoatMint rating

MoatMint rates Therapeuticsmd (TXMD) 7.3 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 4.2 out of 10.

Key metrics

The numbers that frame TXMD today
Market cap
$23.96M
P/E (TTM)
133.8
EV / FCF
-814.6
Gross margin
100%
EV / Sales
6.1
ROIC
0.8%
Div yield
0%
Debt / equity
0.2
52wk Low
$0.99
52wk High
$2.95

TXMD stock rating

How TXMD scores on quality, value, growth, momentum and financial health
7.3out of 10
Good overallHealthy business, full priceTop 27% of ~5,000 US stocks
QualityNeutral4.2/10
GrowthGreat9.2/10
MomentumGreat8.0/10
ValueNeutral4.2/10
Financial HealthGood7.5/10

Growth

Revenue and earnings trend for TXMD
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about TXMD
Is Therapeuticsmd a good buy?
Yes. Therapeuticsmd has excellent momentum, and it outweighs the weak quality here. Growth looks excellent, which supports the long-term business case. We think Therapeuticsmd is selling at a high price, which cuts against the buy case.
What is the market capitalization of TXMD?
Therapeuticsmd's market capitalization is $23.96M.
What is the P/E ratio for TXMD stock?
Therapeuticsmd's current P/E ratio is 133.8.
What is the 52-week high for TXMD stock?
The 52-week high for Therapeuticsmd is $2.95. The current close of $2.07 is 29.8% below that high.
What is the 52-week low for TXMD stock?
The 52-week low for Therapeuticsmd is $0.99. The current close of $2.07 is 109.1% above that low.
Does TXMD stock pay dividends?
Therapeuticsmd does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for TXMD?
Therapeuticsmd's Debt / Equity ratio is 0.18.